Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients

NCT00327834 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.

NCT NCT00327834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00327834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients
Lead sponsor
Lindner Center of HOPE
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
March 31, 2007
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge-eating disorder